{"filing":{"accession_number":"0001213900-26-095146","cik":"0001739174","ticker":"PHGE","company_name":"BiomX Inc.","form":"8-K","filing_date":"2026-08-28","report_date":"2026-08-28","primary_document":"ea0303593-8k_biomx.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026095146/ea0303593-8k_biomx.htm"},"events":[{"id":30392,"run_id":27854,"accession_number":"0001213900-26-095146","anchor_item_number":"8.01","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"BiomX announced a 1-for-10 reverse stock split approved by stockholders on August 25, 2026, with Board authorization on August 28, 2026, and an effective date of September 9, 2026. This is a governance event involving stockholder approval and Board action to amend the Certificate of Incorporation. While reverse splits can signal financial distress or delisting risk, the disclosure here focuses on the corporate action itself rather than any underlying distress, making it a governance matter. The event is material as it affects all stockholders' share structure and trading mechanics, though it does not alter percentage ownership (except for fractional share treatment).","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-08-28","form":"8-K","submitted_at":null,"items":[{"id":32971,"accession_number":"0001213900-26-095146","item_number":"8.01","item_title":"Other Events.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"BiomX announced a 1-for-10 reverse stock split approved by stockholders on August 25, 2026, with Board authorization on August 28, 2026, and an effective date of September 9, 2026. This is a governance event involving stockholder approval and Board action to amend the Certificate of Incorporation. While reverse splits can signal financial distress or delisting risk, the disclosure here focuses on the corporate action itself rather than any underlying distress, making it a governance matter. The event is material as it affects all stockholders' share structure and trading mechanics, though it does not alter percentage ownership (except for fractional share treatment).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T21:02:06.212494+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32971,"accession_number":"0001213900-26-095146","item_number":"8.01","item_title":"Other Events.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"BiomX announced a 1-for-10 reverse stock split approved by stockholders on August 25, 2026, with Board authorization on August 28, 2026, and an effective date of September 9, 2026. This is a governance event involving stockholder approval and Board action to amend the Certificate of Incorporation. While reverse splits can signal financial distress or delisting risk, the disclosure here focuses on the corporate action itself rather than any underlying distress, making it a governance matter. The event is material as it affects all stockholders' share structure and trading mechanics, though it does not alter percentage ownership (except for fractional share treatment).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T21:02:06.212494+00:00","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-08-28"}]}